HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--May 17, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) is pleased to announce that positive results from successful clinical studies of the Company's AlzheimAlert (TM) test will be presented at the upcoming International Congress of Clinical Neurophysiology to be held in Edinburgh, UK from September 10 to 14, 2006. The presentation is entitled "Urine neural thread protein levels in mild cognitive impairment" and the authors are Dr. Ira Goodman, Dr. Stephen Flitman, Dr. Kevin Xie, Dr. Alireza Minagar, and Dr. Ralph Richter.
